Gina enjoys working with her clients to strategize and provide business solutions related to all aspects of patent law—particularly prosecution, post-grant challenges, litigation and due diligence—in the areas of biotechnology, pharmaceuticals, and medical apparatuses. Her clients include public and private life sciences companies, as well as hospitals and universities. Her significant experience includes patent portfolio management and patent counseling, as well as involvement in inter partes reviews (IPR), reexaminations, interferences, and European oppositions. Other experience includes a wide variety of involvement in patent litigation matters and licensing issues. In addition, Gina has experience in patentability opinions, freedom to operate evaluations, intellectual property due diligence, and competitive technology assessments.
In the course of her patent litigation and prosecution work, Gina has worked on a variety of areas in biotechnology and pharmaceutics such as: therapeutics, diagnostics, and prognostics, nucleic acid and protein therapies, small molecule therapies, immunotherapies, virus-based applications, stem cells, therapeutic formulations and delivery systems, vaccine applications, drug screening and drug development platforms, molecular biology reagents, and pharmacogenomics (personalized medicine) in a wide variety of indications (for example, cancer, bacterial and viral infections, genetic diseases, diabetes, neurological disorders, cardiovascular diseases and conditions, mental health conditions, and infertility). In addition, her litigation, due diligence, and prosecution experience extends into the areas of medical devices and apparatuses (including dental technology, cytometry, radiation phantoms, stents, and microfluidics sensor technology).